In multiple sclerosis (MS), DNAM-1 is downregulated on natural-killer (NK) cells and associated with impaired NK-mediated regulation of T-cell activity [19], while it is upregulated on Tregs of progressive MS patients, which can influence their suppressive capacity (Table 2, functional properties are further discussed below) [20]. This evidence concerns the gene CD226 and myeloid sarcoma.